Dimitri Goundis
Amministratore Delegato presso The Medicines Company (Leipzig) GmbH
Profilo
Dimitri Goundis was Chief Executive Officer of Acrongenomics, Inc. until September 2, 2008.
He worked for Hoffman La Roche and Speedel AG from 1988 to 2006.
Dr. Goundis served as Senior Director of Project Management for The Medicines Co., Inc. He received a Certificate in Investment Management from the London Business School, a BS in Chemistry/Biochemistry from the University of London and a PhD in Biochemistry from the University of Oxford.
Posizioni attive di Dimitri Goundis
| Società | Posizione | Inizio |
|---|---|---|
The Medicines Company (Leipzig) GmbH
 The Medicines Company (Leipzig) GmbH Miscellaneous Commercial ServicesCommercial Services The Medicines Co. Leipzig GmbH develops and manufactures pharmaceutical and drug based products. The company provides medicines to the worldwide hospital market sector. The Medicines Co. Leipzig was founded in 1996 and is headquartered in Leipzig, Germany. | Amministratore Delegato | 27/08/2009 |
Precedenti posizioni note di Dimitri Goundis
| Società | Posizione | Fine |
|---|---|---|
Acrongenomics, Inc.
 Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Presidente | 02/09/2008 |
Formazione di Dimitri Goundis
| University of Oxford | Doctorate Degree |
| University of London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Acrongenomics, Inc.
Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
The Medicines Company (Leipzig) GmbH
The Medicines Company (Leipzig) GmbH Miscellaneous Commercial ServicesCommercial Services The Medicines Co. Leipzig GmbH develops and manufactures pharmaceutical and drug based products. The company provides medicines to the worldwide hospital market sector. The Medicines Co. Leipzig was founded in 1996 and is headquartered in Leipzig, Germany. | Commercial Services |
- Borsa valori
- Insiders
- Dimitri Goundis
